An FDA advisory panel concluded that a new drug from BioMarin Pharmaceutical hasn’t been proven to effectively treat the fatal disease called Duchenne muscular dystrophy.
Fda Panel: Biomarin Muscular Dystrophy Not Effective
WSJ.com: Health, Wall Street Journal: Business: Health
Tue, 11/24/2015 - 4:50pm
RELATED ARTICLES
- no title provided in feed
For some who see a therapist, just talking things through isn't enough. Drama therapy allows the patient to relive a moment or play out their biggest fears. More - no title provided in feed
Sen. Mark Kelly joins The Lead More - no title provided in feed
This year, 28,000 pounds of human waste was removed from base camp. The Mount Everest Biogas Project plans to convert this waste into a usable product. More - no title provided in feed
CNN's Victor Blackwell talks to Jazmin Evans who was kept off the transplant list for years. More - no title provided in feed
Jonathan Haidt, social psychologist and author of "The Anxious Generation", explains the dangers of exposing children and teens to smartphones and social media before a certain age and offers tips for parents on how to handle these challenges. More - no title provided in feed
Every year 40 athletes are chosen to race in The Barkley Marathons, and in the last three decades, only 15 people have successfully crossed the finish line More
BING NEWS:
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the ...
04/26/2024 - 1:49 am | View Link - BioMarin stock falls 9% in wake of Q1 report, pipeline updates
Shares of BioMarin (BMRN) were down 9% in afternoon trading Thursday, the day after the company released a Q1 revenue report that fell short of expectations and said it was shutting down four drug ...
04/25/2024 - 8:46 am | View Link - BioMarin drops drug programs in pipeline cull
The cuts of four pipeline prospects come as BioMarin resets its priorities following the slow launch of its hemophilia gene therapy Roctavian.
04/25/2024 - 4:55 am | View Link - Under new leadership, BioMarin axes 4 candidates and centers on 3 assets
After BioMarin’s new leadership conducted a “strategic R&D asset review,” three of its “most productive” assets are being ...
04/25/2024 - 3:10 am | View Link - My son's smile gives me hope for Duchenne muscular dystrophy. A new law could help others
Opinion: Newborn testing can give families a head start on giving a child with the degenerative muscular disease a shot at the best outcome in life.
04/23/2024 - 1:01 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more